{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:11:44Z","timestamp":1784225504523,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFC2503701"],"award-info":[{"award-number":["2022YFC2503701"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022LJ019"],"award-info":[{"award-number":["2022LJ019"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473233"],"award-info":[{"award-number":["82473233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303680"],"award-info":[{"award-number":["82303680"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272742"],"award-info":[{"award-number":["82272742"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.yexcr.2026.114986","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:33:13Z","timestamp":1773909193000},"page":"114986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["AURKA promotes radioresistance in pancreatic cancer via GSK3\u03b2-mediated PTEN phosphorylation at T366"],"prefix":"10.1016","volume":"458","author":[{"given":"Di","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bichun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.114986_bib1","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1245\/s10434-024-15281-1","article-title":"Predictors for long-term survival after resection of pancreatic ductal adenocarcinoma: a systematic review and meta-analysis","volume":"31","author":"Javed","year":"2024","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","article-title":"Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jconrel.2020.06.001","article-title":"Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency","volume":"324","author":"Chen","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.yexcr.2026.114986_bib4","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.3390\/jcm11164866","article-title":"Advances and remaining challenges in the treatment for borderline resectable and locally advanced pancreatic ductal adenocarcinoma","volume":"11","author":"Sulciner","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yexcr.2026.114986_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12885-024-11823-8","article-title":"Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer","volume":"24","author":"Fan","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2026.114986_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.yexcr.2026.114986_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216873","article-title":"RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers","volume":"591","author":"Wolfe","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2026.114986_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110268","article-title":"Numb\/Notch\/PLK1 signaling pathway mediated hyperglycemic memory in pancreatic cancer cell radioresistance and the therapeutic effects of metformin","volume":"93","author":"Zhu","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2026.114986_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110531","article-title":"Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1","volume":"200","author":"Van Matre","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib10","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/1878-0261.13625","article-title":"Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues","volume":"18","author":"Vall\u00e9s-Mart\u00ed","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12915-016-0335-5","article-title":"Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer","volume":"15","author":"Wang","year":"2017","journal-title":"BMC Biol."},{"key":"10.1016\/j.yexcr.2026.114986_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12935-025-03717-x","article-title":"Broussoflavonol B induces S-phase arrest and apoptosis in pancreatic cancer cells by modulating the cell cycle checkpoint through inhibition of the AURKA\/PLK1 pathway","volume":"25","author":"Choe","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2026.114986_bib13","first-page":"739","article-title":"Function of Aurora kinase A in Taxol-resistant breast cancer and its correlation with P-gp","volume":"4","author":"Li","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2026.114986_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11523-019-00662-4","article-title":"Inhibition of Aurora A kinase in combination with chemotherapy induces synthetic lethality and overcomes chemoresistance in myc-overexpressing lymphoma","volume":"14","author":"Park","year":"2019","journal-title":"Targeted Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-021-00571-x","article-title":"PTEN suppresses tumorigenesis by directly dephosphorylating Akt","volume":"6","author":"Bu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.yexcr.2026.114986_bib16","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.gendis.2022.12.015","article-title":"Synthetic lethal approaches to target cancers with loss of PTEN function","volume":"10","author":"Ertay","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.yexcr.2026.114986_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11033-024-10049-y","article-title":"Decoding PTEN: from biological functions to signaling pathways in tumors","volume":"51","author":"Huang","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.yexcr.2026.114986_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ymeth.2014.10.015","article-title":"Kinases, tails and more: regulation of PTEN function by phosphorylation","volume":"77\u201378","author":"Fragoso","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.yexcr.2026.114986_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/or.2024.1430237","article-title":"Post-translational modification of PTEN protein: quantity and activity","volume":"18","author":"Li","year":"2024","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.yexcr.2026.114986_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036095","article-title":"Posttranslational regulation and conformational plasticity of PTEN","volume":"10","author":"Kotelevets","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.yexcr.2026.114986_bib21","doi-asserted-by":"crossref","first-page":"35195","DOI":"10.1074\/jbc.M503045200","article-title":"Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta","volume":"280","author":"Al-Khouri","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2026.114986_bib22","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2174\/187152009789734982","article-title":"An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta","volume":"9","author":"Miyashita","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.yexcr.2026.114986_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2008.05.045","article-title":"Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy","volume":"273","author":"Luo","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2026.114986_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-019-05239-3","article-title":"Regulation of AKT phosphorylation by GSK3beta and PTEN to control chemoresistance in breast cancer","volume":"176","author":"Gao","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.yexcr.2026.114986_bib25","first-page":"4","article-title":"Glycogen synthase kinase 3\u03b2: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer","volume":"7","author":"Uehara","year":"2024","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.yexcr.2026.114986_bib26","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","article-title":"Emerging roles of Aurora-A kinase in cancer therapy resistance","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.yexcr.2026.114986_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40364-024-00651-4","article-title":"The significant others of Aurora kinase a in cancer: combination is the key","volume":"12","author":"Nikhil","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.yexcr.2026.114986_bib28","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1038\/s41467-023-38740-x","article-title":"Hyperphosphorylated PTEN exerts oncogenic properties","volume":"14","author":"van Ree","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.114986_bib29","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.3390\/cancers14225613","article-title":"Targeting PTEN regulation by post translational modifications","volume":"14","author":"Gonz\u00e1lez-Garc\u00eda","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2026.114986_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-015-0375-4","article-title":"Aurora kinase A in gastrointestinal cancers: time to target","volume":"14","author":"Katsha","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.114986_bib31","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.3390\/ijms26146853","article-title":"The role of PI3K\/AKT\/mTOR signaling in tumor radioresistance and advances in inhibitor research","volume":"26","author":"Zhan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.114986_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2026.114986_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.114986_bib34","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/1878-0261.13625","article-title":"Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues","volume":"18","author":"Vall\u00e9s-Mart\u00ed","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115647","article-title":"Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies","volume":"224","author":"du Toit-Thompson","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexcr.2026.114986_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1186101","article-title":"Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s43018-022-00349-2","article-title":"Translational advances in pancreatic ductal adenocarcinoma therapy","volume":"3","author":"Hosein","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.yexcr.2026.114986_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-020-01305-3","article-title":"Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy","volume":"20","author":"Du","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.114986_bib39","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1093\/brain\/awac350","article-title":"Loss of PTEN phosphorylation via single point mutation alters cortical connectivity and behaviour","volume":"145","author":"Binder","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.yexcr.2026.114986_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamaoncol.2022.7949","article-title":"Evaluation of alisertib alone or combined with fulvestrant in patients with endocrine-resistant advanced breast cancer: the phase 2 TBCRC041 randomized clinical trial","volume":"9","author":"Haddad","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.yexcr.2026.114986_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2021.06.012","article-title":"Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies","volume":"154","author":"Lim","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexcr.2026.114986_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218033","article-title":"Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma","volume":"634","author":"Urbanova","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2026.114986_bib43","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1158\/1078-0432.CCR-09-3171","article-title":"Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2","volume":"16","author":"Yang","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.114986_bib44","first-page":"575","article-title":"Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K\/Akt\/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells","volume":"9","author":"Wang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.yexcr.2026.114986_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055289","article-title":"Aberrant glycogen synthase kinase 3\u03b2 is involved in pancreatic cancer cell invasion and resistance to therapy","volume":"8","author":"Kitano","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2026.114986_bib46","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1038\/s41467-018-07644-6","article-title":"GSK3 suppression upregulates \u03b2-catenin and c-Myc to abrogate KRas-dependent tumors","volume":"9","author":"Kazi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.114986_bib47","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1038\/s41467-024-51274-0","article-title":"Fast and deep phosphoproteome analysis with the orbitrap astral mass spectrometer","volume":"15","author":"Lancaster","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.114986_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116663","article-title":"H2AX: a key player in DNA damage response and a promising target for cancer therapy","volume":"175","author":"Prabhu","year":"2024","journal-title":"Biomed. Pharmacother."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:42:21Z","timestamp":1776152541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0014482726001035"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.114986","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AURKA promotes radioresistance in pancreatic cancer via GSK3\u03b2-mediated PTEN phosphorylation at T366","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.114986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114986"}}